Cargando…
Gait speed, cognition and falls in people living with mild-to-moderate Alzheimer disease: data from NILVAD
BACKGROUND: Previous evidence suggests that slower gait speed is longitudinally associated with cognitive impairment, dementia and falls in older adults. Despite this, the longitudinal relationship between gait speed, cognition and falls in those with a diagnosis of dementia remains poorly explored....
Autores principales: | Dyer, Adam H., Lawlor, Brian, Kennelly, Sean P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106668/ https://www.ncbi.nlm.nih.gov/pubmed/32228468 http://dx.doi.org/10.1186/s12877-020-01531-w |
Ejemplares similares
-
European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease—the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow
por: Meulenbroek, Olga, et al.
Publicado: (2016) -
The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
por: Abdullah, Laila, et al.
Publicado: (2020) -
NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease
por: Lawlor, Brian, et al.
Publicado: (2014) -
What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?
por: Murphy, Claire, et al.
Publicado: (2023) -
1494. Impact of Polypharmacy on Gait Speed and Falls in Older People Living with HIV.
por: Kosana, Priya, et al.
Publicado: (2023)